Carvedilol for Pre-primary Prophylaxis of Esophageal Varices in Cirrhosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Carvedilol for Pre-primary Prophylaxis of Esophageal Varices in Cirrhosis — Stella

Home/Cirrhosis/

View on ClinicalTrials.gov

Recruiting

Back to Cirrhosis trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

India

Institute of Liver & Biliary Sciences (ILBS), New Delhi, National Capital Territory of Delhi

Key details

Sponsor

Institute of Liver and Biliary Sciences, India

Enrollment target

~132 participants

Started

September 2010

Primary completion

December 2026

Age range

18 Years – 75 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.